CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells by Piercy, J, Petrova, S, Tchilian, E, Beverley, P

CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells. by Piercy, J, Petrova, S, Tchilian, E, Beverley, P

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany by Waller J, Sullivan E, Piercy J, Black CM, Kachroo S

Get full text

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes by Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V

Get full text

Predictors of Mortality for Patients with COVID-19 in the Rural Appalachian Region by Bhopalwala H, Dewaswala N, Kolagatla S, Wisnieski L, Piercy J, Bhopalwala A, Moka N

Get full text

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015 by Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M

Get full text

CD45 is required for type I IFN production by dendritic cells. by Montoya, M, Dawes, R, Reid, D, Lee, L, Piercy, J, Borrow, P, Tchilian, E, Beverley, P

Qualitative Interviews to Support Development and Cognitive Debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A Patient-Reported Measure of Medication Adherence Devel... by Bentley S, Morgan L, Exall E, Arbuckle R, Rossom RC, Roche N, Khunti K, Higgins V, Piercy J

Get full text

Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice by Taylor PC, Alten R, Gomez Reino JJ, Caporali R, Bertin P, Sullivan E, Wood R, Piercy J, Vasilescu R, Spurden D, Alvir J, Tarallo M

Get full text

Comparison of biologic disease-modifying anti-rheumatic drug rheumatoid arthritis treatment dynamics across five European Union countries by Taylor, P, Alten, R, Gomez-Reino, J, Caporali, R, Bertin, P, Sullivan, E, Wood, R, Piercy, J, Vasilescu, R, Spurden, D, Alvir, J, Tarallo, M

Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice by Taylor, P, Alten, R, Gomez Reino, J, Caporali, R, Bertin, P, Sullivan, E, Wood, R, Piercy, J, Vasilescu, R, Spurden, D, Alvir, J, Tarallo, M

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment by Taylor, P, Alten, R, Gomez Reino, J, Caporali, R, Bertin, P, Sullivan, E, Wood, R, Piercy, J, Vasilescu, R, Spurden, D, Alvir, J, Tarallo, M